Association of early post‐transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation
Diabetic Medicine · 2025
DOI: 10.1111/dme.15441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Christopher A Muir und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Heart Transplantation, Hyperglycemia, Diabetes Mellitus, Type 2, Graft Rejection. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Early post‐transplant hyperglycaemia (EPTH) and post‐transplant diabetes mellitus (PTDM) are common following solid organ transplantation and may be associated with adverse outcomes. We studied the prevalence of EPTH and cumulative 5‐year prevalence of PTDM in a modern cohort of heart transplant recipients who were free from diabetes at baseline as well as the association of EPTH, PTDM and pre‐transplant T2DM with adverse transplant‐related outcomes.
Methods
Retrospective cohort study of heart transplant recipients followed for 5 years at a single centre in Sydney, Australia.
Results
A total of 141 patients were included, of whom 25 had pre‐existing type 2 diabetes mellitus (T2DM) and 116 were free from diabetes at baseline. In patients without pre‐existing T2DM, 88 of 116 (76%) experienced EPTH, which was associated with higher rates of acute rejection and hospitalizations, and lower 5‐year survival. PTDM developed in 45 of 116 (39%) patients, all of whom had experienced EPTH. Both PTDM and pre‐existing T2DM were associated with increased rates of graft rejection and hospitalization, and greater than three‐fold increased likelihood of death compared to patients that remained free from diabetes.
Conclusion
EPTH and PTDM are highly prevalent following cardiac transplantation. EPTH develops within days of transplant and is strongly associated with progression to PTDM. Pre‐existing T2DM, PTDM and EPTH are associated with greater hospitalization, increased episodes of rejection and worse 5‐year survival compared to patients who remained free from diabetes during follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, New South Wales, Australia.
- Department of Endocrinology, St. Vincent's Hospital, Sydney, New South Wales, Australia.
- Department of Heart and Lung Transplant, St. Vincent's Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Christopher A Muir, Lisa M Raven
Zitieren
APA
Muir, C. A., Kuang, W., Muthiah, K., Greenfield, J. R., & Raven, L. M. (2025). Association of early post‐transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation. Diabetic Medicine. https://doi.org/10.1111/dme.15441
Vancouver
Muir CA, Kuang W, Muthiah K, Greenfield JR, Raven LM. Association of early post‐transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation. Diabetic Medicine. 2025. doi:10.1111/dme.15441
BibTeX
@article{Muir2025,
author = {Muir, Christopher A and Kuang, William and Muthiah, Kavitha and Greenfield, Jerry R and Raven, Lisa M},
title = {Association of early post‐transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation},
journal = {Diabetic Medicine},
year = {2025},
doi = {10.1111/dme.15441}
}
EUVIMED